Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Inflammatory Breast Neoplasms × eribulin × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 13 Triple Negative Breast Neoplasms 6 Neoplasm Metastasis 3 Urinary Bladder Neoplasms 2 Urethral Neoplasms 1 Ureteral Neoplasms 1 Recurrence 1 Hemangiosarcoma 1 Hemangioendothelioma, Epithelioid 1 HER2-low Breast Cancer 1 Carcinoma, Transitional Cell 1 Brest Cancer 1 Brain Neoplasms 1

Interventions

Paclitaxel 4 Doxorubicin 3 Cyclophosphamide 3 pertuzumab 2 pembrolizumab 2 Trastuzumab 2 Specimen Handling 2 Radiotherapy 2 trastuzumab biosimilar HLX02 1 ruxolitinib 1 onvansertib 1 olaparib 1 neratinib 1 X-Rays 1 Therapeutics 1 Taxes 1 Tamoxifen 1 Surgical Procedures, Operative 1 Radiation 1 Peripheral Blood Stem Cell Transplantation 1 Palliative Care 1 PF-05280014 1 Ontruzant 1 Ogivri 1 Methods 1 Mesna 1 Melphalan 1 Magnetic Resonance Spectroscopy 1 Injections, Subcutaneous 1 Filgrastim 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡